Investor Relations

For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. (known as Innoviva, Inc. since January 7, 2016), please visit Innoviva, Inc. Investor Relations Press Releases.


Press Releases
Date Title and Summary View
Apr 18, 2017 DUBLIN, April 18, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that data from new studies of VIBATIV® (telava...
Mar 28, 2017 DUBLIN, March 28, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer, will present a corporate overvi...
Feb 27, 2017 DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the fourth quarter and full yea...
Feb 17, 2017 DUBLIN, Feb. 17, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of positive clinical data for TD-14...
Feb 15, 2017 DUBLIN, Feb. 15, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the perio...
Feb 13, 2017 DUBLIN, Feb. 13, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will highlight clinical data on TD-1473, a n...
Feb 2, 2017 DUBLIN, Feb. 2, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that members of management will participate in a fireside chat at the Leerink Partners 6th Annu...
Jan 23, 2017 DUBLIN, Jan. 23, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported new interim data from the Company's ongoing Telavanci...
Jan 17, 2017 DUBLIN, Jan. 17, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that new interim data from the Company's ongoing Tel...
Dec 19, 2016 DUBLIN, Dec. 19, 2016 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today announced that GlaxoSmithKline plc (GSK) and Innoviva, Inc. (Innoviva) have ini...
1
... NextLast
Add to Briefcase = add release to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)